Compounds > doripenem
Page last updated: 2024-08-25

doripenem and Acinetobacter Infections

doripenem has been researched along with Acinetobacter Infections in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (15.00)29.6817
2010's16 (80.00)24.3611
2020's1 (5.00)2.80

Authors

AuthorsStudies
Bonomo, RA; Decker, BK; Hujer, AM; Hujer, KM; Perez, F; Rather, PN1
Aquino, EE; León, CF; Otero, DM; Robledo, IE; Santana, JL; Santé, MI; Vázquez, GJ1
Eom, YB; Kim, HR1
Akbari, R; Bevalian, P; Hakemi-Vala, M; Hashemi, A; Pashaie, F; Pooshang Bagheri, K1
Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S1
Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L1
Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP1
Davies, TA; He, W; Lynch, AS; Queenan, AM1
Clancy, CJ; Doi, Y; Nguyen, MH; O'Hara, JA; Oleksiuk, LM; Press, EG; Shields, RK; Updike, CL1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N1
Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F1
Ansari, M; Gilani, M; Hafeez, A; Latif, M; Munir, T; Najeeb, S; Rehman, S; Saad, N1
Choi, IS; Choi, JA; Jang, SJ; Jeong, SH; Kang, SH; Kim, CM; Moon, DS; Park, G; Park, GC1
Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H1
Alba, V; Marti, S; Sánchez-Céspedes, J; Vila, J1
Mariano, N; Rahal, JJ; Urban, C1
Cantón, R; García, A; Gimeno, C; Gobernado, M1
Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM1
Akers, KS; Beckius, ML; Calvano, T; Hospenthal, DR; Markelz, AE; Mende, K; Murray, CK; Yu, X; Zera, WC1
Rice, LB1

Reviews

2 review(s) available for doripenem and Acinetobacter Infections

ArticleYear
Global challenge of multidrug-resistant Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans

2007
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Sep-01, Volume: 43 Suppl 2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline

2006

Trials

1 trial(s) available for doripenem and Acinetobacter Infections

ArticleYear
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult

2014

Other Studies

17 other study(ies) available for doripenem and Acinetobacter Infections

ArticleYear
Detection of KPC in Acinetobacter spp. in Puerto Rico.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Puerto Rico

2010
Auranofin promotes antibacterial effect of doripenem against carbapenem-resistant Acinetobacter baumannii.
    Journal of applied microbiology, 2022, Volume: 133, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Auranofin; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests

2022
Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Burns; Ceftazidime; Cell Line; Cell Survival; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Melitten; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2019
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin

2013
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Microbial drug resistance (Larchmont, N.Y.), 2013, Volume: 19, Issue:5

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline

2013
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline

2013
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
    Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:3

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis

2013
In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Sulbactam

2014
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
    The new microbiologica, 2015, Volume: 38, Issue:1

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline

2015
In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2015, Volume: 25, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections

2015
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Annals of laboratory medicine, 2016, Volume: 36, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline

2016
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Journal of applied microbiology, 2016, Volume: 121, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins

2016
In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2009
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin

2010
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2010, Volume: 23, Issue:3

    Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins

2010
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
    Infection control and hospital epidemiology, 2011, Volume: 32, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins

2011
Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011